Skip to main content
HairCited

Minoxidil per Alopecia androgenetica

A

Basato su 191 studi (19 meta-analyses, 21 RCTs) con 41,495 partecipanti totali. 159/191 studi mostrano effetti positivi.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dminoxidil\u0026condition\u003Dandrogenetic\u002Dalopecia'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

In sintesi

Minoxidil is strongly supported by extensive research as an effective option that may help promote hair regrowth in people with androgenetic alopecia.

  • 191 studies with over 41,000 participants — one of the most researched hair loss ingredients
  • 83% of studies show positive effects on hair regrowth and density
  • Both topical and oral forms are supported by meta-analyses and RCTs
  • Recent expert consensus guidelines support its use as a first-line option

Key Study Findings

review
Oral Minoxidil for Alopecia Treatment: Risks, Benefits, and Recommendations.
Dose: Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 vs: Placebo Effetto: Comparable efficacy to topical minoxidil; hypertrichosis 24%, shedding 16-22%, peripheral edema 2% None
Review
Androgenetic Alopecia in Women: A Narrative Review of Pathophysiology, Clinical Evaluation, and Treatments.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: women with androgenetic alopecia (female pattern hair loss)

Other
Low-dose oral minoxidil (LDOM) and topical minoxidil: consensus recommendations for managing male and female pattern …
Dose: MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day vs: None Outcome: consensus recommendations for managing pattern hair loss Effetto: None None

Popolazione: hair transplant patients with male and female pattern hair loss (Delphi panel consensus)

non-randomized controlled trial n=60 16 weeks Open-label
Clinical Efficacy and Mechanisms of Microneedling Alone or Combined With Drugs in the Treatment of …
Dose: Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); vs: Placebo Effetto: All groups showed significant decrease in HLSS and increase in hair density post-treatment (p<0.001) p<0.001
Case Reports n=1 Open-label
Plica Neuropathica (Polonica) Secondary to Diffuse Alopecia: A Case Report and Literature Review.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: 62-year-old female with diffuse alopecia and plica neuropathica

review
Antiandrogen therapy for the treatment of female pattern hair loss: A clinical review of current …
Dose: varies by agent and study vs: Placebo Effetto: variable; oral antiandrogens demonstrate some efficacy; topical antiandrogens possibly fewer systemi None

Key Statistics

299

Studi

68291

Partecipanti

Positive

A

Grado

Referenced Papers

Journal of the … 2026
Aesthetic plastic surgery 2025 14 citazioni
Anais brasileiros de … 2025 7 citazioni
Acta dermato-venereologica 2025 4 citazioni
European journal of … 2025 3 citazioni
Australian prescriber 2025 2 citazioni
Acta dermatovenerologica Alpina, … 2025 2 citazioni
International journal of … 2025 1 citazioni
Journal of clinical … 2025 1 citazioni
Skin appendage disorders 2025 1 citazioni
Nature reviews. Disease … 2025
Archives of dermatological … 2025
Annals of dermatology 2025
International journal of … 2024 39 citazioni
Indian journal of … 2024 14 citazioni
Journal of cosmetic … 2024 11 citazioni
Journal of clinical … 2024 10 citazioni
Facial plastic surgery … 2024 8 citazioni
Photodermatology, photoimmunology & … 2024 8 citazioni
American family physician 2024 8 citazioni
Skin health and … 2024 7 citazioni
International journal of … 2024 5 citazioni
SAGE open medical … 2024 3 citazioni
Vestnik oftalmologii 2024 1 citazioni
Drugs 2023 221 citazioni
JAAD international 2023 80 citazioni
Clinical, cosmetic and … 2023 58 citazioni
American journal of … 2023 41 citazioni
Anais brasileiros de … 2023 29 citazioni
Skin appendage disorders 2023 27 citazioni
Archives of dermatological … 2023 16 citazioni
Journal der Deutschen … 2023 5 citazioni
International journal of … 2023 5 citazioni
Journal of cosmetic … 2023 3 citazioni
BMJ case reports 2023 2 citazioni
Clinics in plastic … 2023 1 citazioni
International journal of … 2023 1 citazioni
The Journal of … 2022 170 citazioni
Faculty reviews 2022 44 citazioni
Dermatology and therapy 2022 43 citazioni
Dermatologic therapy 2022 41 citazioni
Journal of cosmetic … 2022 35 citazioni
Journal of cosmetic … 2022 7 citazioni
Cureus 2022 3 citazioni
Facial plastic surgery … 2022
Journal of cutaneous … 2021 44 citazioni
Journal of the … 2021 42 citazioni
Actas dermo-sifiliograficas 2021 3 citazioni
Expert opinion on … 2020 147 citazioni
American journal of … 2020 127 citazioni
International journal of … 2020 58 citazioni
Indian dermatology online … 2020 31 citazioni
Dermatologic clinics 2020 15 citazioni
Facial plastic surgery … 2020 15 citazioni
Alternative therapies in … 2020 11 citazioni
Drug design, development … 2019 320 citazioni
Journal of cosmetic … 2019 100 citazioni
American journal of … 2019 84 citazioni
Expert opinion on … 2019 34 citazioni
Bioscience, biotechnology, and … 2019 9 citazioni
International journal of … 2018 129 citazioni
Journal of the … 2018 114 citazioni
Indian journal of … 2018 79 citazioni
Lasers in medical … 2018 75 citazioni
Dermatologic therapy 2018 63 citazioni
Australian journal of … 2018 8 citazioni
American family physician 2017 141 citazioni
JAMA dermatology 2017 121 citazioni
Current clinical pharmacology 2017 62 citazioni
Actas dermo-sifiliograficas 2017 17 citazioni
BMJ case reports 2017 6 citazioni
Deutsches Arzteblatt international 2016 99 citazioni
The Cochrane database … 2016 18 citazioni
The Medical clinics … 2015 66 citazioni
Current problems in … 2015 8 citazioni
Der Internist 2015
Lasers in surgery … 2014 243 citazioni
Journal of cutaneous … 2014 168 citazioni
Expert opinion on … 2014 57 citazioni
Skin therapy letter 2014 29 citazioni
Journal of drugs … 2014 26 citazioni
Giornale italiano di … 2014 8 citazioni
Giornale italiano di … 2014
Indian journal of … 2013 196 citazioni
Dermatologic clinics 2013 78 citazioni
Journal of cosmetic … 2013 62 citazioni
International journal of … 2013 61 citazioni
Indian journal of … 2013 16 citazioni
Facial plastic surgery … 2013 16 citazioni
International journal of … 2013
The Cochrane database … 2012 15 citazioni
Expert opinion on … 2010 264 citazioni
Current opinion in … 2009 54 citazioni
Seminars in cutaneous … 2009 4 citazioni
American family physician 2009
Current opinion in … 2008 31 citazioni
Nihon rinsho. Japanese … 2008 6 citazioni
Endocrinology and metabolism … 2007 33 citazioni
Clinical interventions in … 2007
Acta dermatovenerologica Alpina, … 2005
Annual review of … 2004 664 citazioni
Revue medicale de … 2004
The journal of … 2003 102 citazioni
Praxis 2003 28 citazioni
American family physician 2003 2 citazioni
American family physician 2003
Clinical and experimental … 2002 61 citazioni
Therapeutische Umschau. Revue … 2002 4 citazioni
American journal of … 2000 18 citazioni
Southern medical journal 2000
International journal of … 1999 16 citazioni
Journal of cutaneous … 1999
Journal of the … 1999
International journal of … 1999
American family physician 1999
Dermatologic clinics 1998 121 citazioni
Annales de dermatologie … 1997
Journal of the … 1984

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

topical:
2-5% solution, twice daily

Limite massimo: 5% topical solution

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
Oral minoxidil: women 1.25 mg/day starting dose (range 0.625-5 mg/day); men 2.5 mg/day (range 1.25-5 -- Positive --
None -- Neutral --
MPHL: 1.25-2.5 mg/day; FPHL: 0.625-1.25 mg/day -- Positive --
Mild group: microneedling alone (8 weeks); Moderate group: microneedling + 5% minoxidil (12 weeks); 16 weeks Positive 60
None -- Mixed 1
varies by agent and study -- Positive --
None -- Positive --
None -- Mixed --

Momento migliore per l'assunzione: Apply to dry scalp morning and evening, at least 4 hours before bed

Safety & Side Effects

Effetti collaterali segnalati

  • Scalp irritation and dryness
  • Initial shedding phase (first 2-8 weeks)
  • Unwanted facial hair growth (especially in women)
  • Dizziness or lightheadedness (rare with topical use)
  • Heart palpitations (rare, more common with oral form)

Interazioni note

  • Antihypertensive medications (additive blood pressure lowering)
  • Topical corticosteroids (may increase absorption)
  • Retinoids (tretinoin may enhance penetration and side effects)

Livello di assunzione massimo tollerabile: 5% topical solution

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Minoxidil help with Alopecia androgenetica?
Based on 299 studies with 68,291 participants, there is strong evidence from multiple clinical trials that Minoxidil may support Alopecia androgenetica management. Our evidence grade is A (Strong Evidence).
How much Minoxidil should I take for Alopecia androgenetica?
Studies have used various dosages. A commonly studied range is 2-5% solution, twice daily. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Minoxidil?
Reported side effects may include Scalp irritation and dryness, Initial shedding phase (first 2-8 weeks), Unwanted facial hair growth (especially in women), Dizziness or lightheadedness (rare with topical use). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Minoxidil and Alopecia androgenetica?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 299 peer-reviewed studies with 68,291 total participants. The overall direction of effect is positive.

Related Evidence

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.